Labrador Iron Ore Royalty Corporation
LIFZF
$21.03
$0.0150.07%
| Weiss Ratings | LIFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | LIFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Excellent | |||
| Growth Index | Weak | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | LIFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.83 | |||
| Price History | LIFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.48% | |||
| 30-Day Total Return | -2.28% | |||
| 60-Day Total Return | -0.03% | |||
| 90-Day Total Return | -4.66% | |||
| Year to Date Total Return | 3.70% | |||
| 1-Year Total Return | 1.50% | |||
| 2-Year Total Return | 1.49% | |||
| 3-Year Total Return | -26.57% | |||
| 5-Year Total Return | 230.88% | |||
| 52-Week High % Change | -16.32% | |||
| 52-Week Low % Change | 5.68% | |||
| Price | LIFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $25.13 | |||
| 52-Week Low Price | $19.90 | |||
| 52-Week Low Price (Date) | Dec 31, 2024 | |||
| 52-Week High Price (Date) | Sep 26, 2024 | |||
| Valuation | LIFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.34B | |||
| Enterprise Value | 1.31B | |||
| Price/Earnings (TTM) | 9.40 | |||
| Earnings Per Share (TTM) | 2.24 | |||
| Earnings Per Share Growth | 7.84% | |||
| Price/Earnings To Growth | 1.20 | |||
| Price/Sales (TTM) | 8.82 | |||
| Price/Book (Q) | 2.76 | |||
| Enterprise Value/Revenue (TTM) | 8.70 | |||
| Price | $21.03 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | 11.50 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | LIFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 63.41M | |||
| Dividend Yield | 10.21% | |||
| Div. Per Share (Most Recent) | $0.52 | |||
| Dividend Per Share (TTM) | $2.15 | |||
| Payout Ratio (TTM) | 96.91% | |||
| Dividend Per Share (Most Recent) | $0.52 | |||
| Company Info | LIFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 416 362 0066 | |||
| Address | 31 Adelaide St. East Toronto, ON M5C 2K3 | |||
| Website | labradorironore.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | LIFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 75.63% | |||
| Profit Margin | 94.70% | |||
| Management Effectiveness | LIFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 11.42% | |||
| Return on Equity | 29.84% | |||
| Income Statement | LIFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 151.14M | |||
| Total Revenue (TTM) | 151.14M | |||
| Revenue Per Share | $2.38 | |||
| Gross Profit (TTM) | 146.60M | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | 114.31M | |||
| Net Income (TTM) | 143.13M | |||
| Net Income Avl. to Common (TTM) | 143.13M | |||
| Total Revenue Growth (Q YOY) | -13.06% | |||
| Earnings Growth (Q YOY) | -33.13% | |||
| EPS Diluted (TTM) | 2.24 | |||
| EPS Diluted Growth (Q YOY) | -32.31% | |||
| Balance Sheet | LIFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 29.82M | |||
| Cash Per Share (Q) | $0.47 | |||
| Total Current Assets (Q) | 61.39M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 487.97M | |||
| Current Ratio (Q) | 1.538 | |||
| Book Value Per Share (Q) | $7.62 | |||
| Total Assets (Q) | 628.74M | |||
| Total Current Liabilities (Q) | 39.93M | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 140.77M | |||
| Total Common Equity (Q) | 487.97M | |||
| Cash Flow | LIFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -138.71M | |||
| Net Change in Cash (TTM) | -5.58M | |||
| Levered Free Cash Flow (TTM) | 68.11M | |||
| Cash from Operations (TTM) | 133.14M | |||
